Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-Demand Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-Demand Treatment

Published:2024-07-11 Issue: Volume: Page:37-43
ISSN:2398-9130
Container-title:EMJ Allergy & Immunology
language:
Short-container-title:EMJ Allergy Immunol

Author:

Cross Caroline E.¹

Affiliation:

1. Reading, UK

Publisher

European Medical Group

Reference11 articles.

1. Maurer M et al. The international WAO/EAACI guideline for the management of hereditary angioedema. The 2021 revision and update. World Allergy Organ J. 2022;77(7):1961-90.

2. Maurer M et al. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One. 2013;8(2):e53773.

3. Geng B et al. Understanding why hereditary angioedema patients often do not carry their on-demand treatment with them. Ann Allergy Asthma Immunol. 2023;131 (5, Suppl 1):S37.

4. Longhurst HJ et al. Real-world outcomes in hereditary angioedema: first experience from the Icatibant outcome survey in the United Kingdom. Allergy Asthma Clin Immunol. 2018;14:28.

5. Lesage A et al. In vitro pharmacological profile of PHA-022121, a small molecule bradykinin B2 receptor antagonist in clinical development. Int Immunopharmacol. 2022;105:108523.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3